Literature DB >> 21061267

Expression analysis of proline rich 15 (Prr15) in mouse and human gastrointestinal tumors.

Dominique Meunier1, Kalicharan Patra, Ron Smits, Andrea Hägebarth, Angela Lüttges, Rolf Jaussi, Matthew J Wieduwilt, Leticia Quintanilla-Fend, Heinz Himmelbauer, Riccardo Fodde, Reinald H Fundele.   

Abstract

Proline rich 15 (Prr15), which encodes a protein of unknown function, is expressed almost exclusively in postmitotic cells both during fetal development and in adult tissues, such as the intestinal epithelium and the testis. To determine if this specific expression is lost in intestinal neoplasias, we examined Prr15 expression by in situ hybridization (ISH) on mouse intestinal tumors caused by different gene mutations, and on human colorectal cancer (CRC) samples. Prr15/PRR15 expression was consistently observed in mouse gastrointestinal (GI) tumors caused by mutations in the Apc gene, as well as in several advanced stage human CRCs. In contrast, no Prr15 expression was detected in intestinal tumors derived from mice carrying mutations in the Smad3, Smad4, or Cdkn1b genes. These findings, combined with the fact that a majority of sporadic human CRCs carry APC mutations, strongly suggest that the expression of Prr15/PRR15 in mouse and human GI tumors is linked, directly or indirectly, to the absence of the APC protein or, more generally, to the disruption of the Wnt signaling pathway.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21061267     DOI: 10.1002/mc.20692

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  7 in total

1.  Cell-Intrinsic Tumorigenic Functions of PPARγ in Bladder Urothelial Carcinoma.

Authors:  Danielle J Sanchez; Rindert Missiaen; Nicolas Skuli; David J Steger; M Celeste Simon
Journal:  Mol Cancer Res       Date:  2021-01-11       Impact factor: 6.333

2.  Molecular Network-Based Identification of Competing Endogenous RNAs in Thyroid Carcinoma.

Authors:  Minjia Lu; Xingyu Xu; Baohang Xi; Qi Dai; Chenli Li; Li Su; Xiaonan Zhou; Min Tang; Yuhua Yao; Jialiang Yang
Journal:  Genes (Basel)       Date:  2018-01-19       Impact factor: 4.096

3.  Effect of proline rich 15-deficiency on trophoblast viability and survival.

Authors:  Katherine C Gates; Lindsey N Goetzmann; Jeremy D Cantlon; Kimberly M Jeckel; Russell V Anthony
Journal:  PLoS One       Date:  2017-04-05       Impact factor: 3.240

4.  PRR15 Is a Novel Diagnostic and Prognostic Biomarker in Papillary Thyroid Cancer and Modulates the Tumor Microenvironment.

Authors:  Lingli Wang; Xiaoqing Deng; Yi Chen; Yixia Zhao; Zhirong Li
Journal:  J Oncol       Date:  2022-09-15       Impact factor: 4.501

5.  Differentially methylated regions in maternal and paternal uniparental disomy for chromosome 7.

Authors:  Katariina Hannula-Jouppi; Mari Muurinen; Marita Lipsanen-Nyman; Lovisa E Reinius; Sini Ezer; Dario Greco; Juha Kere
Journal:  Epigenetics       Date:  2013-11-18       Impact factor: 4.528

6.  WGCNA reveals key gene modules regulated by the combined treatment of colon cancer with PHY906 and CPT11.

Authors:  Shuqin Xing; Yafei Wang; Kaiwen Hu; Fen Wang; Tao Sun; Quanwang Li
Journal:  Biosci Rep       Date:  2020-09-30       Impact factor: 3.840

7.  LncRNA AC007255.1, an immune-related prognostic enhancer RNA in esophageal cancer.

Authors:  Qingqing Wang; Xiaoyan Yu; Ningning Yang; Lu Xu; Yunfeng Zhou
Journal:  PeerJ       Date:  2021-07-14       Impact factor: 2.984

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.